General Electric (GE) PT Lowered to $6 at JPMorgan; Sees EPS/FCF/Dividend All Down ~85%
Get Alerts GE Hot Sheet
Rating Summary:
26 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
(Updated - November 9, 2018 10:29 AM EST)
(updated to add more analyst color)
JPMorgan analyst Stephen Tusa, considered the "ax" in the stock, lowered his price target on General Electric (NYSE: GE) again. This time he cut the target to $6.00 (from $10.00) while maintaining an Underweight rating. Tusa said results were worse than expected on nearly all fronts, including forecasts for FCF and EBITDA moving materially lower.
Tusa added that a material change in language from the 10Q suggests a negative step down in the leverage situation.
The analyst said while sell-side bulls now point to “liquidity concerns” as the driver of share price weakness, this misconstrues what he calls the "Real Bear Case (RBC)" - namely $100 B in liabilities and zero enterprise FCF even after a 95% dividend cut.
While shares are down ~70% from the peak of $30, the move still does not sufficiently reflect the fundamental facts, he said.
Tusa said as the dust continues to settle, they expect the anchor on "EPS/FCF/dividend to all be down ~85% ($2 to $0.30 in FCF), while GECS is now FCF negative by ~$3B, debt will be ~flat (Industrial debt up ~$10B), liability discovery will be up ~$25 B ($3 per share alone), and assets will be down $40 B (i.e., less resources to offset)."
"In other words, while liquidity is certainly debatable, we believe this is not really about liquidity, it’s about a deterioration in run rate fundamentals (by 2020, we believe that 6 of 8 segments will be showing “zero”)," he added.
The firm is 60% below the Street for 2019/2020. The 2019 EPS / FCF per share (GE defined) goes $0.35/$0.31 (Street EPS at $0.85-0.90) and 2020 to $0.41/$0.35 (Street EPS at $1).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte (INCY) PT Raised to $105 at Truist Securities
- Qualcomm (QCOM) PT Raised to $195 at BofA Securities
- Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change, Hot CommentsRelated Entities
JPMorgan, Dividend, Stephen TusaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share